ProQR Therapeutics N.V. (NASDAQ: PRQR)
$1.87
+0.1200 ( +6.86% ) 121.2K
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Market Data
Open
$1.87
Previous close
$1.75
Volume
121.2K
Market cap
$153.53M
Day range
$1.77 - $1.91
52 week range
$1.11 - $3.29
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 1 | May 22, 2024 |
| 6-k | Quarterly Reports | 72 | May 09, 2024 |
| 6-k | Quarterly Reports | 2 | May 08, 2024 |
| 6-k | Quarterly Reports | 9 | Apr 23, 2024 |
| 6-k | Quarterly Reports | 2 | Apr 19, 2024 |
| 20-f | Annual reports | 122 | Mar 13, 2024 |
| 6-k | Quarterly Reports | 2 | Mar 13, 2024 |
| 6-k | Quarterly Reports | 2 | Feb 15, 2024 |
| 6-k | Quarterly Reports | 2 | Jan 19, 2024 |
| 6-k | Quarterly Reports | 2 | Jan 05, 2024 |